Table 2.
Current and potential future therapeutics for LGL leukemia
View large
Current and potential future therapeutics for LGL leukemia

RTK indicates receptor tyrosine kinase; sFas, soluble Fas; and MMP, matrix metalloproteinase.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal